ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Carotid Artery Disease"

  • Abstract Number: 1008 • ACR Convergence 2022

    Endothelial Dysfunction in Axial Spondyloarthritis and Its Association with Clinical Disease Characteristics

    lourdes Ladehesa-Pineda1, Clementina Lopez-Medina2, Maria Angeles Puche Larrubia3, Raquel Granados4 and Eduardo Collantes5, 1Reina Sofia University Hospital/Rheumatology Department/Maimonides Institute for Biomedical Research (IMIBIC), Cordoba, Spain, 2Reina Sofia University Hospital, Rheumatology Department, Jaén, Spain, 3Reina Sofia University Hospital/Rheumatology Department/Maimonides Institute for Biomedical Research (IMIBIC), Granada, Spain, 4Reina Sofia University Hospital/Rheumatology Department/Maimonides Institute for Biomedical Research (IMIBIC), Córdoba, Spain, 5IMIBIC/University of Cordoba/Reina Sofia Hospital, Cordoba, Spain

    Background/Purpose: It has been described an increased presence of cardiovascular risk factors and subclinical atherosclerosis in patients with axial spondyloarthritis (axSpA). Several studies have shown…
  • Abstract Number: 1216 • ACR Convergence 2022

    Subclinical Vascular Disease Is More Prevalent in above-30 Adult Fibromyalgia: A Preliminary Report of a Hospital-based Cross-sectional Study from South India

    Salil Ganu, C. B. Mithun and Jyothi Visalakshy, Amrita Institute of Medical Sciences, Kochi, India

    Background/Purpose: Fibromyalgia is known to be associated with cardiovascular events and mortality. We aimed to compare the prevalence of subclinical atherosclerosis (SAT), a surrogate marker…
  • Abstract Number: 0317 • ACR Convergence 2022

    Full Characterization of the Three Pathways of Complement System in Patients with Systemic Lupus Erythematosus: Relation to Disease Expression

    Ivan Ferraz Amaro1, maría García-González2, carmen Ferrer-Moure2, Fuensanta Gómez-Bernal2, Antonia De Vera-González2, Alejandra González Delgado2, Agustín Francisco González-Rivero2, Yolanda Fernández-Cladera2, Juan Carlos Quevedo Abeledo3 and Federico Díaz-González4, 1Division of Rheumatology. Hospital Universitario de Canarias. Spain., Santa Cruz de Tenerife, Spain, 2Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 3Hospital Universitario Dr. Negrín, Santa Cruz de Tenerife, Spain, 4Hospital Universitario de Canarias, Santa Cruz de Tenerife

    Background/Purpose: Activation of the classical complement (C) pathway by immune complexes is a characteristic of patients with systemic lupus erythematosus (SLE). Accelerated consumption outstrips synthesis…
  • Abstract Number: 0274 • ACR Convergence 2021

    Angiopoietin-Like Protein 4, Apolipoprotein C3 and Lipoprotein Lipase Axis in the Abnormal Lipid Profile of Patients with Rheumatoid Arthritis: Relation to Subclinical Atheromatosis

    juan Carlos Quevedo1, Laura de Armás-Rillo2, Antonia de Vera-González3, Laura Cáceres1, Cristina Almeida1, Alejandra González-Delgado3 and Iván Ferraz-Amaro3, 1Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain, 2Universidad Europea de Canarias, Santa Cruz De Tenerife, Spain, 3Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain

    Background/Purpose: Rheumatoid arthritis (RA) is associated with an increase in cardiovascular (CV) risk, attributed, among other factors, to the existence of an abnormal lipid profile.…
  • Abstract Number: 0448 • ACR Convergence 2020

    Disease-related factors associated to atherosclerotic disease in axial spondyloarthritis. A mutlicenter study with 806 patients.

    Inigo Gonzalez-Mazon1, Ivan Ferraz-Amaro2, Javier Rueda-Gotor3, Lara Sanchez-Bilbao4, David Martinez-Lopez5, Mario Agudo-Bilbao3, Fernanda Genre6, Sara Remuzgo-Martínez6, Veronica Pulito-Cueto6, Alfonso Corrales7, Leticia Lera-Gómez6, Virginia Portilla6, Vanesa Calvo-Río3, Cristina Mata8, Vanesa Hernández-Hernández9, Santos Castañeda10, Esther Francisca Vicente-Rabaneda11, C Fernandez-Carballido12, M Paz Martínez-Vidal13, David Castro-Corredor14, Joaquín Anino-Fernández14, Juan Carlos Quevedo-Abeledo15, Carlos Rodríguez-Lozano16, C. Fernandez-Diaz17, Esther Montes-Perez18, María Luz García Vivar,19, Eva Galínez-Agirregoikoa19, Javier Llorca20, Raquel López-Mejías6, Chamaida Plasencia21, Diana Peiteado22, Alejandro Balsa-Criado23, Nuria Barbarroja24, Lourdes Ladehesa-Pineda25, Rafaela Ortega-Castro26, Eduardo Collantes-Estévez25, Ricardo Blanco4 and Miguel Ángel González-Gay27, 1Hospital Universitario Marques de Valdecilla, Bezana, Spain, 2Division of Rheumatology. Hospital Universitario de Canarias. Spain., Santa Cruz de Tenerife, Spain, 3H.U. Marques de Valdecilla, Santander, Spain, 4Hospital Universitario Marques de Valdecilla, Santander, Spain, 5Hospital Universitario Marques de Valdecilla, Santander (SPAIN), Spain, 6Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic bone Diseases of the Musculoskeletal System, IDIVAL, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain, 7Research group on genetic epidemiology and atherosclerosis in systemic diseases and in metabolic bone diseases of the musculoskeletal system, IDIVAL; and Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain, 8Hospital de Laredo, Santander, Spain, 9Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 10Princesa University Hospital, Universidad Autónoma, Madrid, Madrid, Spain, 11Hospital Universitario de la Princesa, IIS-Princesa, UAM, Madrid, Madrid, Spain, 12H San Juan, Alicante, Spain, 13Hospital General Universitario de Alicante, Alicante, Spain, 14Hospital General Universitario de Ciudad Real, Ciudad Real, Spain, 15Hospital Dr. Negrín, Las Palmas de Gran Canaria, Spain, 16Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain, 17H. Marqués de Valdecilla, Madrid, Spain, 18Diagnóstico Médico Cantabria (DMC), Santander, Spain, 19Hospital Universitario Basurto, Bilbao, Spain, 20School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), Santander, Spain, 21Rheumatology, La Paz University Hospital-IdiPAZ, madrid, Spain, 22Hospital Universitario La Paz-IdiPaz, Madrid, Spain, 23HOSPITAL UNIVERSITARIO LA PAZ, madrid, Spain, 24Rheumatology Department, Reina Sofia University Hospital/ Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ University of Cordoba, Cordoba, Spain, Cordoba, Spain, 25Rheumatology Department, Reina Sofia University Hospital/ Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ University of Cordoba, Cordoba, Spain, Córdoba, Spain, 26Hospital Universitario Reina Sofía, Córdoba, Spain, 27Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain

    Background/Purpose: Cardiovascular (CV) mortality and morbidity is increased in ankylosing spondylitits (AS) due to a process of accelerated atherosclerosis. The disease-related factors involved in this…
  • Abstract Number: 1182 • ACR Convergence 2020

    Increased Prevalence of Carotid Atherosclerosis in Postmenopausal Women with Rheumatoid Arthritis: A Case Control Study

    Dionicio Ángel Galarza-Delgado1, José Ramón Azpiri López2, Iris Jazmín Colunga Pedraza3, Mayra Alejandra Reyes Soto3, Alejandra Pérez Villar3, Itzel Corina Zárate Salinas2, Paola Fernanda Frausto Lerma3 and Salvador Lugo Pérez2, 1Rheumatology Service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Cardiology Service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Mexico, 3Rheumatology service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Mexico

    Background/Purpose: Cardiovascular disease (CVD) is the primary cause of mortality in women in developed countries. CVD risk rises with age, yet for women there is…
  • Abstract Number: 1189 • ACR Convergence 2020

    Serum High-sensitive Cardiac Troponin at Baseline Predict Cardiovascular Events in Rheumatoid Arthritis and Osteoarthritis

    M. Elaine Husni1, Daniel H Solomon2, Mingyuan Shao3, Katherine Wolski3, Steven Nissen3, Stanley Hazen4 and WH Wilson Tang4, 1Cleveland Clinic, Cleveland, OH, 2Brigham and Women's Hospital, Boston, MA, 3Cleveland Clinic Foundation, Cleveland, OH, 4Cleveland Clinic Foundation, Cleveland

    Background/Purpose: In rheumatoid arthritis (RA), excess mortality and inflammation has been attributed to cardiovascular (CV) diseases. High-sensitivity cardiac troponins (hscTnT) allow measurement of cardiac troponin…
  • Abstract Number: 1330 • ACR Convergence 2020

    Subclinical atherosclertoic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study with 806 patients.

    Inigo Gonzalez-Mazon1, Javier Rueda-Gotor2, Ivan Ferraz-Amaro3, Lara Sanchez-Bilbao4, David Martinez-Lopez5, Fernanda Genre6, Natalia Palmou Fontana7, Vanesa Calvo-Río2, Sara Remuzgo-Martínez6, Veronica Pulito-Cueto6, Alfonso Corrales8, Leticia Lera-Gómez6, Virginia Portilla6, Cristina Mata9, Vanesa Hernández-Hernández10, Santos Castañeda11, Esther Francisca Vicente-Rabaneda12, C Fernandez-Carballido13, M Paz Martínez-Vidal14, David Castro-Corredor15, Joaquín Anino-Fernández15, Juan Carlos Quevedo-Abeledo16, Carlos Rodríguez-Lozano17, María Luz García Vivar,18, Eva Galínez-Agirregoikoa18, C. Fernandez-Diaz19, Javier Llorca20, Raquel López-Mejías6, Esther Montes-Perez21, Diana Peiteado22, Chamaida Plasencia23, Alejandro Balsa-Criado24, Nuria Barbarroja25, Lourdes Ladehesa-Pineda26, Rafaela Ortega-Castro27, Eduardo Collantes-Estévez26, Ricardo Blanco28 and Miguel Ángel González-Gay29, 1Hospital Universitario Marques de Valdecilla, Bezana, Spain, 2H.U. Marques de Valdecilla, Santander, Spain, 3Division of Rheumatology. Hospital Universitario de Canarias. Spain., Santa Cruz de Tenerife, Spain, 4Hospital Universitario Marques de Valdecilla, Santander, Spain, 5Hospital Universitario Marques de Valdecilla, Santander (SPAIN), Spain, 6Research group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic bone Diseases of the Musculoskeletal System, IDIVAL, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain, 7UNIVERSITARY HOSPITAL MARQUES VALDECILLA, Santander, Spain, 8Research group on genetic epidemiology and atherosclerosis in systemic diseases and in metabolic bone diseases of the musculoskeletal system, IDIVAL; and Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain, 9Hospital de Laredo, Santander, Spain, 10Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 11Princesa University Hospital, Universidad Autónoma, Madrid, Madrid, Spain, 12Hospital Universitario de la Princesa, IIS-Princesa, UAM, Madrid, Madrid, Spain, 13H San Juan, Alicante, Spain, 14Hospital General Universitario de Alicante, Alicante, Spain, 15Hospital General Universitario de Ciudad Real, Ciudad Real, Spain, 16Hospital Dr. Negrín, Las Palmas de Gran Canaria, Spain, 17Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas de Gran Canaria, Spain, 18Hospital Universitario Basurto, Bilbao, Spain, 19H. Marqués de Valdecilla, Madrid, Spain, 20School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), Santander, Spain, 21Diagnóstico Médico Cantabria (DMC), Santander, Spain, 22Hospital Universitario La Paz-IdiPaz, Madrid, Spain, 23Rheumatology, La Paz University Hospital-IdiPAZ, madrid, Spain, 24HOSPITAL UNIVERSITARIO LA PAZ, madrid, Spain, 25Rheumatology Department, Reina Sofia University Hospital/ Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ University of Cordoba, Cordoba, Spain, Cordoba, Spain, 26Rheumatology Department, Reina Sofia University Hospital/ Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ University of Cordoba, Cordoba, Spain, Córdoba, Spain, 27Hospital Universitario Reina Sofía, Córdoba, Spain, 28Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain, 29Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain

    Background/Purpose: Cardiovascular (CV) mortality and morbidity is increased in ankylosing spondylitits (AS) as compared to the general population. Carotid plaque, considered as a surrogate marker…
  • Abstract Number: 1331 • ACR Convergence 2020

    Carotid Ultrasound Findings in Psoriatic Arthritis: A Case-control Study

    Dionicio Ángel Galarza-Delgado1, José Ramón Azpiri López2, Iris Jazmín Colunga Pedraza3, Diana Elsa Flores Alvarado4, Octavio Ilizaliturri Guerra4, Paola Fernanda Frausto Lerma3, Itzel Corina Zárate Salinas2, Alejandra Pérez Villar3, Mayra Alejandra Reyes Soto3, Salvador Lugo Pérez2 and Andrea Cecilia Garza Acosta5, 1Rheumatology Service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Cardiology Service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Mexico, 3Rheumatology service, Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma Nuevo León, Monterrey, Mexico, 4Rheumatology Service, Hospital Universitario “Dr. José Eleuterio González, Universidad Autónoma Nuevo León, Monterrey, Nuevo Leon, Mexico, 5Radiology Service, Hospital Universitario “Dr. José Eleuterio González, Universidad Autónoma Nuevo León, Monterrey, Nuevo Leon, Mexico

    Background/Purpose: Patients with psoriatic arthritis (PsA) have an increased risk of cardiovascular disease (CVD). The carotid ultrasound, which measures both carotid intima-media thickness (cIMT) and…
  • Abstract Number: 1393 • ACR Convergence 2020

    Systemic Sclerosis: Subclinical Aterosclerosis and Morbimortality

    Miriam Retuerto1, Jose Luis Rosales2, Maria Martin1, Beatriz Joven1 and Patricia E Carreira1, 1Hospital universitario 12 de octubre, Madrid, Spain, 2Hospiten Rambla, Santa Cruz de Tenerife, Spain

    Background/Purpose: Rheumatic diseases are associated with accelerated atherosclerosis, and an increase in cardiovascular morbidity and mortality. This process is mediated by classic cardiovascular risk factors…
  • « Previous Page
  • 1
  • 2
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology